P. Driguez

发表

1 INFLUENCE OF HEPARIN MIMETICS ON THE ASSEMBLY OF THE FGF-FGFR 4 SIGNALING COMPLEX

K. Saxena, H. Schwalbe, M. Mohammadi, 2010 .

Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin.

J. Herbert, J. Hérault, J. Mallet, 2001, Chemistry.

Synthesis of thrombin-inhibiting heparin mimetics without side effects

J. Herbert, M. Petitou, J. Lormeau, 1999, Nature.

Synthesisof thrombin-inhibitingheparinmimetics without sideeffects

J. Herbert, M. Petitou, J. Lormeau, 2022 .

Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes.

P. Driguez, D. Moyer, B. de Lignières, 1993, Fertility and sterility.

Tamoxifen Treatment Does Not Induce Endometrial Hyperplasia in Postmenopausal Women

P. Touraine, P. Driguez, F. Kuttenn, 1996 .

Experimental proof for the structure of a thrombin-inhibiting heparin molecule.

S. Pérez, J. Herbert, J. Hérault, 2001, Chemistry.

New synthetic heparin mimetics able to inhibit thrombin and factor Xa.

J. Herbert, J. Hérault, M. Petitou, 1999, Bioorganic & medicinal chemistry letters.

Synthesis of Natural and Nonnatural Heparin Fragments: Optimizations and Applications toward Modulation of FGF2‐Mediated FGFR Signaling

P. Driguez, 2013 .

Synthesis and biological activity of a new anti-factor Xa pentasaccharide with a C-interglycosidic bond

J. Herbert, J. Mallet, M. Petitou, 1997 .

Synthetic oligosaccharides as active pharmaceutical ingredients: lessons learned from the full synthesis of one heparin derivative on a large scale.

P. Potier, P. Driguez, Patrick Trouilleux, 2014, Natural product reports.

Kilogram‐scale Production of Synthetic Heparin Analogs: Some Chemical Considerations

P. Potier, P. Driguez, Patrick Trouilleux, 2018, Protecting Groups.

Synthesis of Conformationally Locked Carbohydrates: A Skew-Boat Conformation of L-Iduronic Acid Governs the Antithrombotic Activity of Heparin.

J. Herbert, S. Das, J. Mallet, 2001, Angewandte Chemie.

First Synthetic Carbohydrates with the Full Anticoagulant Properties of Heparin.

J. Herbert, C. V. van Boeckel, M. Petitou, 1998, Angewandte Chemie.

Synthesis of transition-state analogues as potential inhibitors of sialidase from Influenza virus.

B. Barrère, G. Quash, P. Driguez, 1994, Carbohydrate research.

Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells

J. Walter, J. Pocock, L. Pradier, 2022, Glia.

The Structure of Synthetic Oligosaccharides in Relation to Factor IXa Inhibition

J. Herbert, J. Hérault, F. Bono, 2002, Thrombosis and Haemostasis.

Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin.

J. Herbert, J. Mallet, M. Petitou, 2003, Biochimie.

Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'.

J. Herbert, M. Petitou, P. Duchaussoy, 1999, Carbohydrate research.

Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition.

J. Herbert, M. Petitou, M. Ceccato, 1999, Carbohydrate research.

Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimetics.

J. Herbert, J. Hérault, M. Petitou, 1999, Bioorganic & medicinal chemistry letters.

A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture

B. Barrère, G. Quash, M. Aymard, 1997, Archives of Virology.

Synthesis of Conformationally Locked L-Iduronic Acid Derivatives. Direct Evidence for a Critical Role of the Skew-Boat 2S0 Conformer in the Activation of Antithrombin by Heparin.

J. Herbert, S. Das, J. Mallet, 2002 .

SR123781A, a Synthetic Heparin Mimetic

J. Herbert, J. Hérault, P. Savi, 2001, Thrombosis and Haemostasis.

First Synthetic Carbohydrates with the Full Anticoagulant Properties of Heparin.

J. Herbert, C. V. van Boeckel, M. Petitou, 1998, Angewandte Chemie.

Dichlorotetrakis(1,1‐dimethylethyl)di‐μ‐hydroxyditin

P. Driguez, 2012 .

NMR and DFT analysis of trisaccharide from heparin repeating sequence.

O. Malkina, P. Driguez, M. Hricovíni, 2014, The journal of physical chemistry. B.

[Systematic hysteroscopy prior to in vitro fertilization].

P. Driguez, J. Mayenga, J. Belaisch‐ALLART, 2003, Gynecologie, obstetrique & fertilite.

Characterization of Glycosaminoglycan (GAG) Sulfatases from the Human Gut Symbiont Bacteroides thetaiotaomicron Reveals the First GAG-specific Bacterial Endosulfatase*

D. Spillmann, D. Bonnaffé, A. Benjdia, 2014, The Journal of Biological Chemistry.

Preparation of 1-Methoxycarbonyl-1-t-Butyldimethylsilyloxy Epoxides. Their Transformation into 3-Hydroxy 2-Acetal-Esters and certain 3-Hydroxy 2-Keto-Esters

P. Driguez, A. Doutheau, B. Pujol, 1992 .

Influence of Heparin Mimetics on Assembly of the FGF·FGFR4 Signaling Complex

K. Saxena, H. Schwalbe, M. Mohammadi, 2010, The Journal of Biological Chemistry.

Poly(ethylene glycol acrylate)‐functionalized hydrogels for heparan sulfate oligosaccharide recognition

D. Papy-Garcia, F. Siñeriz, Dominique Singabraya, 2017, Journal of molecular recognition : JMR.

Lack of induction of endometrial hyperplasia with tamoxifen

P. Touraine, P. Driguez, F. Kuttenn, 1995, The Lancet.

Influence of Heparin Mimetics on Assembly of the FGF·FGFR4 Signaling Complex

K. Saxena, H. Schwalbe, M. Mohammadi, 2010, The Journal of Biological Chemistry.

Synthetic oligosaccharides as active pharmaceutical ingredients: lessons learned from the full synthesis of one heparin derivative on a large scale.

P. Potier, P. Driguez, Patrick Trouilleux, 2014, Natural product reports.

[Degradation of copper IUDs in utero. The process of metallic corrosion. A scanning electron microscope study].

J. Berthou, P. Driguez, F. C. Chrétien, 2003, Gynecologie, obstetrique & fertilite.